BREAKING NEWS: Supreme Court Grants Petition and Cross-Petition for Certiorari in Amgen v. Sandoz

Amgen v. Sandoz (filgrastim)  •  Approved Biosimilar Products  •  Biosimilar News  •  BPCIA and Related U.S. Statutes

The Supreme Court has granted Sandoz’s petition for certiorari, and Amgen’s cross-petition for certiorari in Amgen v. Sandoz.  

The Order is excerpted below and can be found here:

15-1039  SANDOZ INC. V. AMGEN INC., ET AL.

15-1195  AMGEN INC., ET AL. V. SANDOZ INC.

The motion of Apotex, Inc., et al. for leave to file a brief as amici curiae is granted. The petitions for writs of certiorari are granted. The cases are consolidated and a total of one hour is allotted for oral argument.

Stay tuned for further updates and analysis.

Download PDF

Comments are closed.